2014
DOI: 10.1097/pec.0000000000000178
|View full text |Cite
|
Sign up to set email alerts
|

Elevated Lidocaine Serum Concentration After Subcutaneous Lidocaine Administration Using a Needle-Free Device in Pediatric Patients

Abstract: We report several cases in which pediatric patients at our institution have elevated lidocaine levels in toxicology screens after subcutaneous injection of lidocaine using a needle-free device. The purpose of this article is to report 4 cases in which pediatric patients have elevated lidocaine levels in toxicology screens after J-Tip administration. In particular, the article highlights 2 cases in which children younger than 3 years had lidocaine levels in the toxic range. Although the literature has reported … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 3 publications
0
6
0
Order By: Relevance
“…A recently published case series reported on 4 children with elevated serum lidocaine levels after J tip lidocaine administration. 15 Though the clinical significance of this is unknown, this study did not evaluated for toxic lidocaine levels in children and this may have been unrecognized. However, based on direct observation of the children immediately after the administration of the J tip, no children showed clinical signs of lidocaine toxicity including dizziness, disorientation, seizures, chest pain or difficulty breathing.…”
Section: Resultsmentioning
confidence: 97%
“…A recently published case series reported on 4 children with elevated serum lidocaine levels after J tip lidocaine administration. 15 Though the clinical significance of this is unknown, this study did not evaluated for toxic lidocaine levels in children and this may have been unrecognized. However, based on direct observation of the children immediately after the administration of the J tip, no children showed clinical signs of lidocaine toxicity including dizziness, disorientation, seizures, chest pain or difficulty breathing.…”
Section: Resultsmentioning
confidence: 97%
“…When lidocaine is used as an antiarrhythmic drug, goal blood therapeutic levels range between 1.5 and 5 mcg/ml. Adverse effects have been reported in literature with therapeutic lidocaine blood levels, especially in patients under three years of age [ 21 23 ]. The two patients that presented neurological symptoms were infants and had the highest blood lidocaine levels in our series (over 2 mcg/ml).…”
Section: Discussionmentioning
confidence: 99%
“…For this reason, we consider it important to monitor neurological status closely and to determine blood lidocaine levels within the first 24 hours of treatment to promptly detect patients at risk of high systemic absorption and, therefore, avoid toxicity. If neurologic manifestations appear and no other explanation is found, lidocaine toxicity must be suspected, and infusion must be stopped even if blood levels were not in the toxic range, especially in the younger patients [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Adverse events appear minimal. Elevated lidocaine serum concentrations after use have been found in children, however, clinical relevance is unknown 81 …”
Section: On the Horizonmentioning
confidence: 99%